Nanogen Moves Ahead With New Microarray System After FDA Warning
A warning letter issued to San Diego-based Nanogen Aug. 11 highlights the continued focus of the agency's in vitro diagnostic regulators on analyte-specific reagents (ASRs)
A warning letter issued to San Diego-based Nanogen Aug. 11 highlights the continued focus of the agency's in vitro diagnostic regulators on analyte-specific reagents (ASRs)